+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07109154

Study of Advanced Non-Small Cell Lung Cancer Patients Starting First-Line Treatment in Brazil Observing Clinical Profiles and Treatment Patterns Including Real-World Data and Oncologist Survey

Led by AstraZeneca · Updated on 2026-05-13

200

Participants Needed

7

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective, observational, multicenter study to collect and analyze clinical and demographic data from patients with advanced non-small cell lung carcinoma NSCLC starting first-line oncological treatment. This study aims to describe the epidemiological characteristics of NSCLC patients in Brazil, assess treatment patterns, and evaluate how these choices align with established guidelines over an average of two years. Additionally, a survey targeting thoracic and generalist medical oncologists in Brazil will explore factors influencing treatment decisions. The study involves extracting data from electronic medical records of approximately 200 patients treated at seven participating centers between January 2025 and January 2026. Eligible patients have unresectable or metastatic NSCLC and are beginning their first-line treatment. The survey will complement this data by gathering insights from oncologists about their treatment selection processes, enabling comparison with real-world clinical data. Participants will be monitored through their medical records to collect relevant clinical and demographic information. Researchers will evaluate treatment patterns, epidemiological details, and the influence of tumor mutations and PD-L1 expression on therapy choices. The study will also analyze survey responses from oncologists to understand variations in first-line treatment decisions. The total study duration is approximately two years, encompassing data collection and analysis phases.

CONDITIONS

Brief Title

DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

Research Team

A

AstraZeneca Clinical Study Information Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here